These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1491181)

  • 1. Evaluation of the behavior of carcinoembryonic antigen in cirrhotic patients.
    Collazos J; Genollà J; Ruibal A
    Int J Biol Markers; 1992; 7(4):244-8. PubMed ID: 1491181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical and laboratory evaluation of the behavior of tissue polypeptide antigen in liver cirrhosis.
    Collazos J; Genollá J; Ruibal A
    Digestion; 1992; 53(3-4):157-61. PubMed ID: 1291404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Preoperative Serum CEA Level Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma Through the Epithelial-Mesenchymal Transition.
    Yoshikawa M; Morine Y; Ikemoto T; Imura S; Higashijima J; Iwahashi S; Saito YU; Takasu C; Yamada S; Ishikawa D; Teraoku H; Takata A; Yoshimoto T; Shimada M
    Anticancer Res; 2017 Mar; 37(3):1169-1175. PubMed ID: 28314278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum concentrations of laminin in cirrhosis of the liver.
    Collazos J; Díaz F; Genollá J
    Gut; 1993 Jul; 34(7):974-6. PubMed ID: 8344586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD66b, CD66c and carcinoembryonic antigen (CEA) are independently regulated markers in sera of tumor patients.
    Grunert F; Daniel S; Nagel G; von Kleist S; Jantscheff P
    Int J Cancer; 1995 Nov; 63(3):349-55. PubMed ID: 7591230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AFP, CEA, CA 19-9 and TPA in hepatocellular carcinoma.
    Maussier ML; Valenza V; Schinco G; Galli G
    Int J Biol Markers; 1990; 5(3):121-6. PubMed ID: 1704905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoembryonic antigen in serum in diseases of the liver and pancreas.
    Khoo SK; Mackay IR
    J Clin Pathol; 1973 Jul; 26(7):470-5. PubMed ID: 4727056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the tumor marker carbohydrate antigen 50 in liver cirrhosis. Pathogenetic considerations.
    Collazos J; Genolla J; Ruibal A
    Clin Nucl Med; 1993 Jan; 18(1):56-9. PubMed ID: 8422722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma endothelin-1 levels in liver cirrhosis.
    Bruno CM; Neri S; Sciacca C; Caruso L
    Int J Clin Lab Res; 2000; 30(4):169-72. PubMed ID: 11289706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-associated glycoprotein-72 serum levels complement carcinoembryonic antigen levels in monitoring patients with gastrointestinal carcinoma. A longitudinal study.
    Guadagni F; Roselli M; Amato T; Cosimelli M; Mannella E; Perri P; Abbolito MR; Cavaliere R; Colcher D; Greiner JW
    Cancer; 1991 Dec; 68(11):2443-50. PubMed ID: 1933781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the liver in clearance and excretion of circulating carcinoembryonic antigen (CEA).
    Thomas P; Zamcheck N
    Dig Dis Sci; 1983 Mar; 28(3):216-24. PubMed ID: 6337795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer-associated antigen CA 15.3 in liver cirrhosis.
    Collazos J; Genolla J; Ruibal A
    Acta Oncol; 1992; 31(7):741-4. PubMed ID: 1476754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum carcinoembryonic antigen elevation in benign lung diseases.
    Yang Y; Xu M; Huang H; Jiang X; Gong K; Liu Y; Kuang X; Yang X
    Sci Rep; 2021 Sep; 11(1):19044. PubMed ID: 34561515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoembryonic antigen (CEA) in patients with malignant and non-malignant diseases.
    Alsabti EA; Kamel A
    Neoplasma; 1979; 26(5):603-9. PubMed ID: 230422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of serum tumor markers carcinoembryonic antigen, CA 19-9, CA 125, and CA 15-3 in pre-orthotopic liver transplantation evaluation.
    Pissaia A; Bernard D; Scatton O; Soubrane O; Conti F; Calmus Y
    Transplant Proc; 2009 Mar; 41(2):682-4. PubMed ID: 19328956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholestasis and hepatic metastases: a factor contributing to extreme elevations of carcinoembryonic antigen.
    O'Brien MJ; Bronstein B; Zamcheck N; Saravis C; Burke B; Gottlieb LS
    J Natl Cancer Inst; 1980 Jun; 64(6):1291-4. PubMed ID: 6246298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined evaluation of preoperative serum sialyl-Tn antigen and carcinoembryonic antigen levels is prognostic for gastric cancer patients.
    Takahashi I; Maehara Y; Kusumoto T; Kohnoe S; Kakeji Y; Baba H; Sugimachi K
    Br J Cancer; 1994 Jan; 69(1):163-6. PubMed ID: 8286201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Importance of Determining Preoperative Serum Concentration of Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen in Assessing the Progression of Colorectal Cancer.
    Halilovic E; Rasic I; Sofic A; Mujic A; Rovcanin A; Hodzic E; Kulovic E
    Med Arch; 2020 Oct; 74(5):346-349. PubMed ID: 33424087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum leptin concentrations correlate with soluble tumour necrosis factor receptor levels in patients with cirrhosis.
    Lin SY; Wang YY; Sheu WH
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):805-11. PubMed ID: 12460331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of unexplained carcinoembryonic antigen elevation after curative treatment of locally advanced rectal cancer.
    Lee SU; Jwa E; Kim DY; Kim TH; Baek JY; Cha Y; Chang HJ; Oh JH
    Int J Clin Oncol; 2018 Oct; 23(5):924-929. PubMed ID: 29774483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.